ZNF217_pLX307 Citations (1)

Originally described in: Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in beta-Catenin-Active Cancers.
Rosenbluh J, Mercer J, Shrestha Y, Oliver R, Tamayo P, Doench JG, Tirosh I, Piccioni F, Hartenian E, Horn H, Fagbami L, Root DE, Jaffe J, Lage K, Boehm JS, Hahn WC Cell Syst. 2016 Sep 28;3(3):302-316.e4. doi: 10.1016/j.cels.2016.09.001. PubMed Journal

---

Articles Citing ZNF217_pLX307

Articles
ZNF217 promotes ovarian cancer progression by impacting multiple pivotal steps in the metastatic process. Wardrup KC, Hoffman J, Pandya MJ, Navarathna N, Tulapurkar ME, Padmanabhan A. NPJ Precis Oncol. 2025 Dec 4;9(1):392. doi: 10.1038/s41698-025-01153-8. PubMed

If you have published an article using this material, please email us at to have your article added to this page.